Information about the consequences of human exposure to radiation in the former Soviet Union has recently become available. These data add new insights and provide possible answers to several important questions regarding radiation and its impact on occupational and public health. The 1986 Chernobyl accident initiated a major and early increase in childhood thyroid cancer that resulted from ingestion of iodine-131 (1311) by young children living in the most heavily contaminated areas of Belarus, Ukraine, and Russia. No significant additional cancer or other adverse medical effects have yet been reported in the affected populations and among clean-up workers. Major psychological stress independent of radiation dose has been observed in those people thought to be exposed. During the early days of the atomic energy program in the former Soviet Union, some unfortunate events occurred. The country's first atomic test in Semipalatinsk in 1949 exposed over 25,000 people downwind from the blast to significant doses of fission products, especially 1311. During the late 1940s and the early 1950s nuclear material production facilities were developed near Chelyabinsk in the South Ural Mountains, which resulted in major releases into the environment and significant overexposures for thousands of workers and nearby populations. Chronic radiation sickness was observed early in exposed workers, and increases in leukemia and other cancers were also reported. The series of plutonium inhalationrelated lung cancers and fatalities among workers exposed in that first decade appears to be unique. Long-term consequences of chronic radiation sickness and four decades of follow-up are being described for the first time. Villagers downstream from the plant consumed high levels of 137Cs and 90Sr and, it is reported, manifested increases in leukemia from internal and external exposures. Although the 4G-year databases for retrospective dosimetry and epidemiology studies are just beginning to be integrated and evaluated, preliminary evaluations suggest that there may be graded, significant dose-rate amelioration factors for cancer and leukemia risks in workers and the general population relative to the risk data on the Japanese atomic bomb survivors. Even for plutonium-induced lung cancers in workers, such a dose-rate effect may be evident. These experiences give us insight into the consequences of protracted radiation at high and low doses and rates. If these findings are validated and confirmed, they can provide information that reduces some of the uncertainties in retrospective radiation dosimetry and radiation risk estimates (especially for low-level, chronic exposures) for activities related to medicine as well as the handling of nuclear materials and nuclear facility decommissioning, decontamination, and demilitarization. -Environ Health Perspect 105(Suppl 6): 1385-1391 (1997) 
Introduction
There are important lessons to be learned much about previous radiation events, even from the radiation events that occurred in some that occurred more than 40 years earthe former Soviet Union. In recent years, lier. It is important to note that most of especially since 1991, we have learned these radiation exposures were related to the military-industrial nuclear fuel cycle. They therefore provide new and different information from that in the traditional databases obtained from medical radiology exposures and instantaneous external exposures from atomic weapon detonations, which are the current basis for almost all radiation risk estimates. Thus, this new information can provide an independent source of radiation risk estimations and can add unique information about the role of protracted external and internal radionudide exposures in radiation risk.
When these new data from the former Soviet Union become fully available, it is hoped they will provide the scientific community and decisionmakers with independent information regarding risks from low, medium, and high radiation doses and rates. One limitation of the current information on low and medium radiation doses is that they are extrapolated from high-dose and dose-rate information using conservative models.
These new data have an underlying problem common to all retrospective studies of radiation exposures and their consequences, i.e., the set of uncertainties that are associated with the reconstruction of radiation dose and the verification and validation of possible adverse health effects. Any careful follow-up study must attempt to use all possible means to reduce uncertainties associated with both dose and effect. With respect to effect, since the human exposures invariably are accidental, one is faced with the additional problem of specification of the relation of location and time of possibly exposed persons to the event(s). It is easier to provide estimates of group collective dose, but this does not always lead to accurate individual dose estimates. The confirmation and validation of all the facets of dose reconstruction can be aided by the use of modern tools of biological and physical dosimetry as well as newer models and methods of database management. Independent corroboration and ascertainment of pathological and clinical information will also require considerable attention.
Although the tragic accident in Ukraine at Chernobyl in April 1986 is the most well known, other events recently have been described that involved serious worker and population exposures. Two Acute radiation syndrome was diagnosed in 145 Chernobyl workers and rescue personnel; two died immediately, one more died of a heart attack, and 28 died within 2 months of burns and radiation sickness (8) . Dosimeters used at the time of the explosion had a 20-mSv limit, so estimates of higher doses are based on clinical and biological end points (9 Evacuations took place during the weeks following the accident such that by September 1986 some 116,000 people were reported to have been relocated. Thirty hours after the accident, the 49,000 inhabitants of nearby Pripyat were evacuated and within 3 days, the 11,000 occupants of 15 villages within the 10-km zone of the reactor were also removed. By May 7, 42,000 additional people from 83 settlements within the 30-km zone were also evacuated. The rest, mainly in Belarus, were evacuated throughout the summer of 1986 (11) .
The whole-body doses to the 4 million people in heavily contaminated areas (i.e., > 37 kBq m2, five times the levels from fallout from atmospheric weapons tests) are still being estimated (12) . Based on past experience, the apparent low average dose estimates at this time make it unlikely that there will be measurable increases in leukemias or other cancers from the wholebody exposures of the population (13) . There are plans for joint epidemiology studies to determine if the incidence of leukemias was increased (11) .
The principal medical consequence of Chernobyl to date is a significant increase in childhood thyroid cancer, which appears to be directly related to consumption of radioiodine-laden milk during May and June 1986. About 400,000 persons had thyroid radioiodine measurements performed, including about 100,000 children then under the age of 15 (Table 1 ). While about (15) . It is likely that the final incidence will rise further, up to about 3000 to 6000 cases ( Figure 1) .
Recently, there have been reports of possible increases in cataracts in children exposed to low linear energy transfer (LET) radiation, and the preliminary data suggest the possibility that the radiation dose threshold for this condition may be quite low, if it exists at all (16 (Table 3) . During this decade, the mean external dose to men was less than 1 Sv. In addition to the oncologic risk, workers who were heavily exposed during the 1948 to 1958 period were at risk for chronic radiation sickness (CRS). The condition is characterized by chronic fatigue, depression, and an altered blood picture (18) . The occupational doses during that decade were quite high, averaging about 3 Gy, and included about 11% of the workforce receiving an average of 6.3 Gy external radiation. After 1958, radiation dose rates were markedly reduced and no workers employed after that date were reported to manifest CRS.
The leukemia rate in workers at the reprocessing plants peaked about 2 to 5 years after the peak exposure rates and is in agreement with that observed in Japanese atomic bomb survivors (19) . The data also suggest that the leukemia excess relative risk is about 1.4 per Gy, which is approximately 3-fold less than that for the atomic bomb survivors (17) . This might suggest that protracted exposure lowers the risk but does not markedly change the latency period.
Lung cancer mortality was elevated in the radiochemical plant workers and was even higher in workers at the plutonium production facility but not in the nuclear reactors where all exposures were primarily from external sources (Table 5 ) (19) . Lung cancer mortality in workers at the nuclear plants does not appear elevated in exposed groups, some of whom averaged over 5 Sv (Table 6) .
From (Table 7 ) (20) .
From about 50 years of age onward, the age-specific lung cancer mortality rate was 2 to 3 times higher in Pu-burdened workers than in reactor workers or the general population. The reactor workers, despite large doses (mainly external low LET) did not experience increased mortality rates with increasing dose, at least in the range studied ( Table 8) .
The villages along the Techa River downstream from the MAYAK plant were subjected to effluent releases, especially during the first 5 years of the plant's operation.
High concentrations of 90Sr and 137Cs were incorporated into the local food and water supply. As a result, internal radionuclide doses reached very significant levels in the dosest villages ( Table 9 ). Some of the population and some of the heavily exposed workers had symptoms of chronic radiation syndrome. Five to 20 years later, acute leukemia and chronic myelogenous leukemias were recorded in the affected populations (21) . Initial evaluations suggest an absolute leukemia risk factor of 0.48 to 1.1 per 104 person-years (PY) Gy, a value some 3 to 5 times lower than that for the atomic bomb survivors (2) . The 90Sr bone burdens and doses were high, and the adjacent marrow was heavily irradiated. Coupled with the worker leukemia data and compared to other studies in which the Of particular concern is the first explosion on 29 August 1949. Table 10 shows that approximately 25,000 people reportedly were exposed to average doses more than 130 mSv, and about 10% exceeded 1 Sv (22 20 MBq/m2 (23) .
The complex at Krasnoyarsk is largely underground. Little is known of any exposure problems. On the banks of the Yenisey River in Siberia, there is concern about radioactive effluents that may have been released. There are reports of contamination at levels up to 10 times that of background levels (23) .
Nuclear-powered submarines and surface vessels have had their share of mishaps, releases, and overexposures, but an integrated evaluation of consequences is not yet available.
Discussion and Conclusions
One of the major post-cold war issues is the clean-up, decommissioning, and possible decontamination of sites associated with the manufacture and testing of atomic weapons. In the United States, for example, total clean-up cost estimates range up to a trillion dollars over the next several decades, assuming a policy of complete restoration to preatomic era levels is implemented. Perhaps the radiation lessons from the former Soviet Union will provide significant relevant radiation exposure and health effects information that will be useful in setting priorities for the order in which the sites are to be cleaned up and will assist in identifying sites where the risk to the nearby population may truly be minimal.
Compilation of these data, which constitute a collective dose that is likely to be larger than that received by the atomic bomb survivors, provides the potential for a human database for chronic, protracted low and high LET radiation that is unique in the world. If the preliminary indications suggested are indeed validated, radiation protection will gain several important new insights and tools. We will be able to confirm whether the animal studies were correct in indicating that the average latency period appears to become longer in many if not most cancers when the dose rate is reduced (1). We will learn the essential factors that relate plutonium lung burdens to lung cancer risk, an important factor in understanding lung cancer risks from radon daughter product inhalation. We already know from animal studies that the risk for leukemia from protracted relative to acute radiation appears to be quite low. From the Techa River 90Sr exposures to people, we may learn if there is also a significant human radiation leukemia dose-rate deduction factor. Additionally, the dinical information on chronic radiation syndrome is unique and may provide better insights into the significant pathways involved in initial injury and subsequent repair of radiosensitive systems. This information can assist in improved planning for treatment of unintentional or accidental overexposures. The special demonstration of childhood sensitivity to Chernobyl's radioiodineinduced thyroid abnormalities unfortunately is still unfolding. The dramatic inverse relationship between age and sensitivity is one of the initial observations, as is the relatively short latency period in children between exposure and onset of disease.
The cost of the cold war was enormous and still is not fully calculated. Cost of radiation health effects, disease, and environmental degradation must be included. As large as these costs appear to all of society, they are small relative to those of an atomic war. Society so far has been successful in implementing a nuclear deterrent, a victory for us all. However, the experience of these early atomic workers in the former USSR and their neighbors taught us that the consequences of significant radiation overexposure cannot be ignored. These exposed people should be considered radiation heroes, and we must learn all we can from their costly experiences.
The data also show us that at very low doses (in the range of natural background radiation), radiation consequences indeed may be negligible and controllable. The data also add a new dimension to our knowledge about radiation and its effects and show how large radiation doses must be to initiate demonstrable latent health effects.
It is only with this kind of fullspectrum information, which permits us to integrate radiation quality and dose distribution in space and time, that radiation protection philosophy will become based more firmly on sound and solid science. Information about which exposures are significant and which are not must be validated carefully before being incorporated into any radiation databases. That this process has begun is reassuring. This radiation legacy is one from which we we all must benefit as we address the potential for a peaceful and effective role for the atom in medicine, industry, and society.
